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Ruminococcin-A (RumA) is a peptide antibiotic with post-translational modifications
including thioether cross-links formed from non-canonical amino acids, called
lanthionines, synthesized by a dedicated lanthionine-generating enzyme RumM. RumA
is naturally produced by Ruminococcus gnavus, which is part of the normal bacterial
flora in the human gut. High activity of RumA against pathogenic Clostridia has been
reported, thus allowing potential exploitation of RumA for clinical applications. However,
purifying RumA from R. gnavus is challenging due to low production yields (<1 µg L−1)
and difficulties to cultivate the obligately anaerobic organism. We recently reported the
reconstruction of the RumA biosynthesis machinery in Escherichia coli where the fully
modified and active peptide was expressed as a fusion protein together with GFP. In
the current study we developed a scale-up strategy for the biotechnologically relevant
heterologous production of RumA, aimed at overproducing the peptide under conditions
comparable with those in industrial production settings. To this end, glucose-limited
fed-batch cultivation was used. Firstly, parallel cultivations were performed in 24-
microwell plates using the enzyme-based automated glucose-delivery cultivation system
EnPresso R© B to determine optimal conditions for IPTG induction. We combined the
bioprocess development with ESI-MS and tandem ESI-MS to monitor modification of
the precursor peptide (preRumA) during bioreactor cultivation. Dehydration of threonine
and serine residues in the core peptide, catalyzed by RumM, occurs within 1 h after IPTG
induction while formation of thioether cross-bridges occur around 2.5 h after induction.
Our data also supplies important information on modification kinetics especially with
respect to the fluctuations observed in the various dehydrated precursor peptide
versions or intermediates produced at different time points during bioreactor cultivation.
Overall, protein yields obtained from the bioreactor cultivations were >120 mg L−1 for
the chimeric construct and >150 mg L−1 for RumM. The correlation observed between
microscale and lab-scale bioreactor cultivations suggests that the process is robust and
realistically applicable to industrial-scale conditions.
Keywords: lantibiotic, ruminococcin-A, bioprocess development, recombinant protein production,
Escherichia coli
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INTRODUCTION
The accelerated growth of resistant pathogenic bacteria against
the existing battery of anti-infective agents has prompted efforts
in developing alternative drug candidates that possess multiple
mechanisms of action to counter the engrossing effect of
disease burdens. Lantibiotics possess characteristics that are
very attractive to this research area and therefore, they are
highly considered as alternative drug candidates to fight bacterial
resistances (Cotter et al., 2013; Dischinger et al., 2014). However,
their application in medicine is limited by low product yields
and cultivation difficulties that is usually associated with the
use of native producers to purify the desired compounds. That
is the reason why despite the urgent needs for potent anti-
infective agents, only few companies have invested little efforts in
developing them, as well as presumed low profits (Servick, 2015).
In a recent report, we assessed the chemical synthetic methods
and biological means as production routes for lanthipeptides and
arrived at the conclusion that in vivo production in microbial
cells is a realistic alternative to attain industrially viable quantities
(Ongey and Neubauer, 2016).
Ruminococcin-A (RumA) is a class II lanthipeptide (also
called lantibiotic because of its antibacterial activity) produced
by the obligate anaerobe Ruminococcus gnavus E1. It was shown
that the peptide can effectively kill pathogenic Clostridia (Dabard
et al., 2001; Gomez et al., 2002), making it a potential candidate
for disease treatment in humans and livestock, and perhaps
it even may be utilized as preservative in the food industry.
R. gnavus by its nature as an obligate anaerobic bacterium already
poses substantial cultivation challenges that would certainly
hinder the development of an efficient and robust production
process. To overcome these limitations, we reconstructed the
biosynthesis pathway of RumA in Escherichia coli and showed
that all the desired post-translational modifications (PTMs) were
correctly formed in the peptide resulting in a 3-membered ring
compound shown in Figure 1D (Ongey et al., 2018). Two main
genes are responsible for the biosynthesis and modifications
of RumA namely; rumA which encodes the precursor peptide
(preRumA) and rumM which encodes the dual-functional
lanthionine synthetase (RumM). The leader peptide of preRumA
(Figure 1A) serves as signaling moiety which RumM identifies
and interacts with, to enable its activity on the core segment
(Repka et al., 2017). The PTM process follows a series of
events characterized by dehydration of threonine and serine
residues in the core peptide into dehydrobutyrine (Dhb)
and dehydroalanine (Dha), respectively. Michael-type addition
cyclization reactions between the sulfhydryl group of cysteine
and the resulting Dhb and Dha produce a lanthionine (Lan) or
a methyllanthionine (MeLan) cross-bridge respectively (Schnell
et al., 1988; Arnison et al., 2013; Yang and van der Donk, 2015;
Repka et al., 2017). We applied this knowledge in developing the
heterologous biosynthesis route. Moderate amounts of modified
RumA precursor (6 mg L−1) was obtained with complex media
cultivations in shake flasks (Ongey et al., 2018).
Class II lanthionine synthetases like the RumM are generally
called LanM enzymes. They are bifunctional, possessing an
N-terminal dehydratase domain and a C-terminal cyclase domain
(Knerr and van der Donk, 2012). In vitro characterization
of some LanM enzymes have revealed the use of ATP to
phosphorylate serine or threonine, and ADP/Mg2+ as cofactors
to eliminate the phosphate esters to yield Dha and Dhb
(Xie et al., 2004; Bierbaum and Sahl, 2009; Ma et al., 2014;
Shimafuji et al., 2015; Repka et al., 2017). Tandem mass
spectrometry assays revealed that phosphorylation occurs in
a unidirectional N- to C-terminal catalytic mode (Lee et al.,
2009). However, conflicting reports exist about the catalytic
modes of the different lanthipeptides (Lubelski et al., 2009;
Krawczyk et al., 2012). Studies elsewhere suggest that the
modifying enzyme may require longer time to catalyze formation
of PTMs (Thibodeaux et al., 2014, 2016; Repka et al., 2017),
but the modification machineries of lanthipeptides are too
complex, severely hindering quantification of kinetic events
involving lanthionine synthetases. Mass spectrometry assays have
a potential in this regard because of its efficiency in detecting
and distinguishing peptide species that are relevant to determine
the type of changes that occur during the dehydration and
cyclization reactions. Electrospray ionization mass spectrometry
(ESI-MS) has been previously employed to quantify the relative
concentrations of intermediates of class II precursor peptide
during an in vitro LanM enzyme catalysis (Thibodeaux et al.,
2014), but such an approach have not been attempted for
in vivo systems.
The challenges encountered when expressing lanthipeptides
in heterologous systems indicate that achieving good expression
levels of the essential genes may not be an antidote for
low production yield, but also to keep the cells viably active
during the long cultivation period is required to guarantee
the formation of desired PTMs. Reports suggest that some
factors that influence cultivation like pH, aeration and cultivation
medium may as well-contribute to the yields of some lantibiotics
(Mortvedt-Abildgaa et al., 1995; Liu et al., 2005; Pongtharangku
and Demirci, 2007; Chaney et al., 2009; Jiang et al., 2015).
Although all these studies were performed with the natural
producers, it is conceivable to anticipate such scenarios
also for recombinant production. Thus, applying fed-batch
cultivation techniques in the context of consistent bioprocess
development may allow, aside from high cell densities, increasing
yields of lantibiotics by adjusting physical parameters and
medium composition.
High through-put optimization using a convenient fed-batch
type technique like EnBase R© (Šiurkus et al., 2010; Glazyrina
et al., 2012; Krause et al., 2016) allows controlled E. coli
cultivations using a variety of conditions in microwell plates,
while still ensuring high cell density growth. Feeding rates in the
enzyme-based glucose delivery cultivation system is controlled
by the amount of enzyme added, which generates a quasi-
linear increase of the cell density. The strength of this technique
was demonstrated for the non-ribosomally synthesized peptide
valinomycin wherein the two complex non-ribosomal peptide
synthetases responsible for its biosynthesis were reconstituted
in E. coli and the system was optimized to attain 10 mg L−1
yield under lab-scale conditions (Li et al., 2014) and more than
2 mg L−1 under mimicked heterogenous large-scale conditions
(Li et al., 2015).
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FIGURE 1 | Post-translational modifications (PTMs) of ruminococcin-A by RumM. The dehydratase domain of the RumM enzyme converts serine and threonine
residues in the core peptide of preRumA (A) into a phosphorylated intermediate (B) which subsequently undergoes an elimination reaction to yield a
dehydro-intermediate (C). The cyclase domain then conjugates the dehydroamino acid residues to cysteinyl thiols via a Michael-type addition cyclization reaction to
yield the three-membered ring compound (D).
The primary aim of the current study was to use RumA as
an example to establish a process by rationally selecting suitable
conditions from microwell plate cultivations and transfer to a
larger-scale (3.7-L bioreactor, KLF Bioengineering, Switzerland).
This therefore underscores a reasonably consistent approach to
develop a high density fed-batch bioprocess for production of
antimicrobial peptides and the potential for attaining economic
viability. The secondary objective was to use the bioreactor set-
up as a tool to gain insights into the kinetics of preRumA
modifications by RumM. Thus, the present work combines
bioprocess development approaches and ESI-MS and tandem
ESI-MS as plausible tools to realize in vivo kinetic studies of
lanthipeptide biosynthesis. The data reported herein, to the best
of our knowledge, is the first recombinant process development
study for lanthipeptides production with E. coli, using lab-
scale bioreactors.
MATERIALS AND METHODS
Bacterial Strains Description
Wild-type E. coli W3110 strain was applied as the expression
host. This strain was transformed with the bicistronic vector
pLEOgrA∗M1 (see Supplementary Figure S1). This vector
harbors the genes that encodes the ruminococcin-A precursor
peptide (preRumA) as a fusion construct to the C-terminus
of GFP, as well as the ruminococcin-A lanthionine synthetase
(RumM). The transformed strain was named E. coli W3110
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pLEOgrA∗M1 (Ongey et al., 2018). The GFP-preRumA
fusion construct had a TEV cleavable site linking GFP to
the precursor peptide and a single Gly/Arg mutation at
position −1 of the preRumA sequence (Figure 1) to enable
complete cleavage of the leader sequence by trypsin. The
genes encoding the chimeric fusion construct (His6-GFP-
TEV-preRumA) and RumM are arranged in an operon on the
pLEOgrA∗M1 vector.
Pre-experiments in 24 Deep-Well Plates
The EnPresso B R© growth system (Enpresso GmbH, Berlin,
Germany) was applied for parallel cultivation of E. coli
strain W3110 pLEOgrA∗M1 under different growth and
induction conditions. Regular 24-square deep-well plates
(Ritter, Schwabmünchen, Germany) were used for the pre-
experiments. E. coli W3110 pLEOgrA∗M1 was first grown
in 100 mL EnPresso B medium in a 500-mL Ultra Yield
FlaskTM closed on top using 0.2 µm re-sealable and sterile
AirOtopTM membranes (both Thomson Instrument Company,
United States), incubated in an orbital shaker (Infors HT,
Switzerland, 5 cm amplitude) at 30◦C, 250 rpm overnight,
attaining an optical density (OD600) of around 7–8 after 14–16 h.
Prior to induction, the 24 deep-well plate was prepared by
adding the desired amounts of IPTG for induction of protein
expression and glucoamylase which releases glucose into the
medium (see Supplementary Figure S2). This generated 24
different experiments representing variation in feeding rates and
IPTG concentrations. The same amount of chloramphenicol
added at the beginning of the cultivation (34 µg mL−1) was
also added to the main culture at this time and 3 mL of
the shake flask culture were supplied to the different wells
of the plates. Sterile Breathable Films (Starlab, Hamburg,
Germany) were used to seal the plates and incubated in the
orbital shaker under the same conditions as before. At the
end of the cultivation, the final pH of each well was measured
and the respective OD600 of the cultures were estimated by
manually diluting 200 µl of the culture and measuring the
optical density using an Ultraspec 3300 spectrophotometer
(Amersham, Germany).
Online GFP Fluorescence, DO, and pH
Measurements in Microwell Plates
Information obtained from the pre-experiments allowed us to
design new experiments to evaluate certain parameters that affect
a production process. The same conditions described for the
pre-experiments in the previous section were replicated in four
different plates. The first plate was a sterile 24 shallow-well flat-
bottom plate (Ritter GmbH, Schwabmünchen, Germany) that
was used to measure online GFP fluorescence signals [expressed
as relative fluorescent unit (RFU)] using a SynergyTM Mx
monochromator-based multimode microplate reader (Biotek).
The auto-fluorescence of a gfp− strain was also measured
as a control. The second plate was a 24 shallow-well flat-
bottom HydroDish R© (HD24) plate (PreSens Precision Sensing
GmbH) that possessed a pH sensor at the bottom of each
well, and the third 24 shallow-well flat-bottom OxoDish R©
(OD24) plate, also from PreSens, was equipped with oxygen
sensors at the bottom of each well. The fourth plate was a
24 deep-well flat-bottom HydroDish (HD24-DW) plate. The
HydroDish and OxoDish plates are sterile single use microwell
plates, possessing pre-calibrated optical pH and DO sensors,
configured to respectively measure pH and dissolved oxygen
concentrations (DO) on-line. Culture volume in each well of
the deep-well plate was set at 3 mL while the microwell plates
were maintained at 1 mL per well. Duetz System sandwich
covers and cover clamps (Enzyscreen, Heemstede, Netherlands)
were applied to circumvent unprecedented reduction of liquid
levels via evaporation. The growth of cultures in the first
row of the fourth plate were determined at-line by manually
diluting 5 µl of the culture in a 1-cm cuvette and estimating
the concentration of cells at 600 nm using an Ultraspec 3300
spectrophotometer (Amersham). At the end of the cultivation,
1 mL culture from each well of the regular 24 shallow-well flat-
bottom plate were collected in 1.5-mL Eppendorf tubes and
centrifuged in a Himac/CT15RE centrifuge (VWR, Leuven) for
1 min at 16,000× g at 4◦C. Cell pellets were stored at−20◦C.
Growth Media, Preculture, and
Inoculation Conditions for the Fed-Batch
Bioreactor Cultivations
For the bioreactor cultivations, the preculture was prepared
in two steps. First, a 20-mL LB medium culture in a 125-
mL Ultra Yield Flask with AirOtop membrane was inoculated
from actively growing colonies from a fresh LB agar plate and
incubated for 7 h. Secondly, 500 µL of the pre-seed culture
was used to inoculate 50 mL EnPresso B medium, which was
supplemented with 3 U L−1 glucoamylase for controlled, linear
glucose release. The preculture was incubated for 18 h. For
the precultures 250-mL single-use polycarbonate sensor flasks
(SFS-HP5-PSt3, PreSens Precision Sensing GmbH, Germany),
which allow on-line monitoring of pH, DO and biomass, were
used. All precultures were supplemented with 34 µg mL−1
chloramphenicol and incubated at 30◦C and 200 rpm.
The initial volume of the mineral salt medium (MSM) used
for the bioreactor cultivations was 1.95 L and composed of:
14.6 g L−1 K2HPO4, 4.0 g L−1 NaH2PO4 × 2H2O, 2.0 g L−1
Na2SO4, 2.5 g L−1 (NH4)2SO4, 0.5 g L−1 NH4Cl, 1.0 g L−1
(NH4)2-H-citrate and 0.1 mL L−1 antifoam PPG2000 that were
autoclaved in situ and then complemented with sterile 0.1 g L−1
thiamin (filtered through 0.2 µm PTFE filter), 2 mL of a 1M
solutions of MgSO4 × 7H2O, 2 mL L−1 trace elements and
9.0 g L−1 glucose (added from pre-autoclaved stock solutions).
The trace elements solution was prepared as a 500X stock
containing 0.5 g L−1 CaCl2 × 2H2O, 0.18 g L−1 ZnSO4 × 7H2O,
0.1 g L−1 MnSO4 × H2O, 20.1 g L−1 Na2-EDTA, 16.7 g L−1
FeCl3 × 6H2O, 0.16 g L−1 CuSO4 × 5H2O, 0.18 g L−1
CoCl2 × 6H2O, 0.085 g L−1 Na2SeO3 × 5H2O, 0.14 g L−1
Na2MoO4, and 0.725 g L−1 Ni(NO3)2 × 6H2O.
The bioreactors were inoculated with the EnPresso B
precultures, which were in the linear growth phase (OD583
of 9–12, Supplementary Figure S3) to initial OD583 of
approximately 0.3.
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Bioreactor Cultivation Conditions
For fed-batch cultivations, a 3.7-L KLF benchtop bioreactor (KLF
2000, Bioengineering AG Switzerland) with a maximum working
volume of 3.0 L was used.
The cultivation temperature was kept constant at 30◦C and
the pH maintained at 7 ± 0.05 through controlled addition of
25% (v/v) ammonia solution. Stirring was performed using two
six-blade Rushton impellers. The initial stirring speed was set to
400 rpm, whereas the initial air flow rate was set to 0.05 vvm. Both
values were alternatively manually increased stepwise to ensure
enough oxygen supply to the culture (DO > 15%). The stirring
speed was increased in 100 steps until the full capacity of the
reactor was reached (1,450 rpm). The air flow rate was gradually
increased up to about 4 vvm.
The fed-batch cultivations were performed with an initial
batch phase until glucose was completely depleted, followed by
feeding phase where the glucose feed solution (with 50% w/v of
glucose) was added exponentially at a specific growth rate (µset)
of 0.35 h−1 (corresponding to approximately 70% of µmax in the
batch phase) according to Eq. 1.
F(t) = F0 · eµset ·t (1)
The initial feed rate (g h−1) was calculated according to Eq. 2,
where Yx/s the biomass/substrate yield (calculated from the batch
phase), Si the concentration of the feeding solution, and X0
and V0 the biomass concentration (calculated from a correlation
between previous OD583 and cell dry weight (CDW) measured
values) and bioreactor liquid volume at the end of the batch
phase, respectively.
F0 = µsetYx/s · Si (tX0V0) (2)
The culture was induced with 200 µM IPTG when a stirring
speed of 1,300 rpm and aeration rate of 2 vvm were reached. The
inducer was added to the culture broth as well as to the feeding
solution. After induction, the feeding rate was kept constant and
eventually decreased to avoid anaerobic growth. Induction was
performed for 10 or 21 h as given in the text.
In order to avoid undesired magnesium limitations, 4 mL
of 1M MgSO4 was added every time the OD583 showed an
increment of 20. Foam formation was suppressed by addition of
small amounts of antifoam 204 (Sigma, Germany) when needed
(maximum amount of less than 1 mL during the cultivation).
Sampling and Analytical Methods During
the Bioreactor Cultivations
During the cultivation sampling was performed every
1.5 h. At every sampling point, the OD583 of the culture
broth was measured off-line in duplicates, manually with a
spectrophotometer (Ultraspec 3000, GE Healthcare, Winsted,
CT, United States, OD583-Photometer) and additionally with the
automated pipetting system Cedex Bio HT Analyzer R© (OD583-
Cedex; Roche Diagnostics International AG, Switzerland) with
the OD Bio HT test kit (Roche Diagnostics International AG,
Switzerland). Also, 2 mL aliquots were sampled in pre-weighted
1.5-mL tubes and dried at 80◦C after centrifugation (4◦C,
6,500× g, 10 min) for later CDW determination. In addition, the
supernatant of the samples were analyzed with the Cedex Bio HT
Analyzer to assess consumption of glucose, Mg2+, PO34, NH3,
and accumulation of acetate with the test kits: Glucose Bio HT,
Magnesium Bio HT, Phosphate Bio HT, NH3 Bio HT, and Acetate
V2 Bio HT (Roche Diagnostics International AG, Switzerland).
For preRumA peptide purification, pelletized cells from 2 mL
samples (4◦C, 6,500× g, 10 min) were stored at−20◦C.
Ruminococcin-A Extraction and Analysis
Cell pellets were resuspended in lysis buffer (20 mM Tris-HCl
pH 8, 300 mM NaCl, 10 mM imidazole, 10% glycerol) and
the cells were lysed by sonicating on ice using the UP200S
sonicator (Hielscher Ultrasonics GmbH, Teltow, Germany, 1 mm
sonotrode diameter) for 10 min with 30% duty cycle and 30 s
on/off intervals. The lysates were centrifuged for 15 min at
16,000 × g at 4◦C to remove cell debris. Clarified lysates
were purified using His SpinTrap columns (GE Healthcare,
United Kingdom) and all samples were eluted in 0.5 mL elution
buffer (20 mM Tris-HCl pH 7.4, 300 mM NaCl, 500 mM
imidazole). The eluents were dialyzed in dialysis buffer (50 mM
Tris-HCl pH 8, 150 mM NaCl, 1 mM DTT, 0.5 mM EDTA)
and protein concentrations were estimated using the NanoDrop
ND-1000 Spectrophotometer (Peqlab Biotechnologie, Erlangen,
Germany). Samples from each elution were processed for SDS-
PAGE analyses. Fresh homemade TEV protease was added (at
a ratio of 1:100 w/w) to the dialyzed protein samples and then
incubated overnight at 4◦C. TEV digestion yielded preRumA,
which was then extracted and purified using C18-ZipTips
(Merck, Darmstadt, Germany). ZipTips-processed samples were
used for mass spectrometric analyses as described later.
SDS-PAGE and Quantification of
His6-RumM and His6-GFP-TEV-preRumA
His SpinTrap column-purified samples obtained after dialysis
were analyzed using 10% standard SDS gels. Buffers and gel
recipes were assembled following standard procedures. SDS
loading buffer was added to the samples and heated for 5 min
at 95◦C. BSA samples, used as standards for quantification,
were prepared in the same manner and loaded on the gels
alongside tested samples. All gels were visualized by staining with
Coomassie G-250. Gels were scanned using a Konica Minolta
c554 series PCL scanner. The areas of the bands were estimated
using ImageJ and then compared against the BSA standards to
obtain approximate quantities in mg L−1.
Mass-Spectrometric Analyses
Samples purified using ZipTips were dried using a Concentrator
Plus vacuum (Eppendorf, Hamburg, Germany) and subsequently
resolubilized in 50% HPLC-grade acetonitrile. Dissolved samples
were directly injected into a nanoLC-coupled Thermo Orbitrap
Fusion Mass Spectrometer (Thermo Fisher Scientific) with a
nano electrospray ion source. The samples were introduced into a
capillary which was then heated by applying a high voltage across
it to produce ions that are separated and measured by the orbitrap
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mass analyzer. The five times charged precursor preRumA ion
(m/z = 1089.72) identified in the mass spectrum (MS1) was
selected and channeled to the ion-routing multipole where it was
fragmented, processed in the C-trap and analyzed by the orbitrap
mass analyzer (MS2). A detailed description of the MS procedure
is given in a previous publication (Ongey et al., 2018).
RESULTS
Well-Plate Cultivations
Parallelized microwell plate cultivations were used to evaluate
the behavior of E. coli W3110 pLEOgrA∗M1 under process-
relevant conditions using on-line monitoring of DO and pH
in EnPresso B cultures. Glucoamylase concentrations in the
EnPresso B growth medium were varied from 0.8 to 2.4 U L−1 to
determine the optimal glucose release rate. Before distribution to
the 24-microwell plates the strain was first cultivated in a PreSens
sensor shake flask. From the OD of the cultures measured,
it was clear that the strain grew normally during cultivation
(Figure 2A). Data recorded for the DO and pH during the first
14 h of cultivation were indicative of a typical E. coli growth
profile (Figures 2B,C). Cells took up freely available glucose
initially present in the EnPresso B medium during the first 5 h of
cultivation and hence the growth profile exhibited characteristics
of a typical batch cultivation, shown by the consistent drop
in DO signals to about 40%. The rapid switch to glucose-
limited growth was evident within 2 h after this drop, where
the DO increased to 75% and remained stable at this level. Slow
decrease in pH throughout the entire cultivation period was also
observed (Figure 2C).
Induction of the initial culture was performed after 14 h of
cultivation in 24-microwell plates with varying concentrations
of IPTG and glucose feeding rates. Oxygen limitation could be
detected at the start of plate measurements as all 24 cultures
had initial DO values around 0%. This was due to lack of
aeration since the culture was at a standstill during distribution
into the wells. However, as aeration resumed, DO signals
increased to about 25–40%, with slight variations which was
dependent on the rate of glucose release in culture medium
(Figure 2B). It is worth noting that growth was rapid between
the period 14–20 h due to the addition of the booster tablet
from the EnBase system, providing complex nutrients and by
the additionally added biocatalyst (Figure 2A). Apparently,
increasing the amount of glucoamylase (and consequently the
rate of glucose release) had a minimum effect on the DO
(Figure 2B). The booster tablet also led to an initial increase of
the pH in dependence on the glucose release rate and a slower
decline afterward (Figure 2C), so that all cultures remained
at a pH above 6.6 until the end of the cultivation. Variations
in pH observed across the culture wells in each column may
be because all four wells in the column also received different
concentrations of IPTG (refer to Supplementary Figure S2).
The pH dropped with increasing rate of glucose release as
shown in Figure 2C. In summary, all the cultures demonstrated
a seemingly stable growth profile that mimicked a traditional
fed-batch cultivation scenario.
Examining the GFP fluorescence signals in the different
cultures of the 24-microwell plate quickly gives the impression
that product formation is negatively affected over long periods
of cultivation. However, this may not necessary be the case as
the SDS-PAGE analyses of HisTrap spin column-purified extracts
from all the wells did not show the same trend. It could easily be
identified that IPTG concentration influenced expression in all
cases. For instance, navigating vertically through the wells of each
column (e.g., column 1: A1→B1→C1→D1) as shown in the left
panel of Figure 3, it is clearly visible that expression intensifies
with increasing strength of induction. Conversely, increasing
the rate of glucose release resulted in significant decreases
in fluorescence signals approximately 10 h after induction.
However, induction strength still had a positive influence on
measured GFP fluorescence signals before this point. Averagely,
there was significant variation in GFP signals across each row of
the 24 microwell plate especially at higher induction strength.
Analysis of the final product extracted from the wells indicated
that excess glucose feeding did not have a positive impact on
production (see wells A6, B6, C6, D6 in comparison to their
counterparts in the same row), especially in cultures where IPTG
concentrations were low. Meanwhile supplying excess glucose
to the culture increased growth rate and consequently produced
higher biomass yields, the same procedure is counterproductive
with respect to target protein expression levels. Taking all
these into account, IPTG concentrations in the range of 100–
500 µM was considered suitable for effective cultivation of E. coli
strain W3110 pLEOgrA∗M1 under glucose-limited conditions
to ensure optimal production of His6-GFP-TEV-preRumA∗ and
Hs6-RumM. Therefore, a high specific growth rate at the time of
induction (70% of µmax) and an IPTG concentration of 200 µM
were selected for the following bioreactor cultivations.
Bioreactor Cultivations
In order to evaluate the potential of E. coli W3110 pLEOgrA∗M1
for the biotechnological production of RumA, two fed-batch
cultivations were performed in a 3.7-L lab-scale bioreactor. The
strain had a maximum specific growth rate of 0.50 h−1 in the
batch phase. The depletion of the initial glucose marking the end
of the batch phase, could be observed via the sudden increase
in the DO at ∼10 h (Figure 4B and Supplementary Figure
S5). Exponential feeding was performed with 50% (w/v) glucose
solution until induction with 200 µM IPTG (∼15 h), followed
by constant feeding rate. During the fed-batch phase glucose
concentrations in the bioreactor remained always limiting and
acetate accumulation was controlled below 2 g L−1 by eventual
reduction of the feeding rate (Supplementary Figure S6).
A constant RQ value around 1 and a kLa value between 1,000 and
1,500 h−1 was reached during both cultivations, which showed a
good reproducibility (Figure 4 and Supplementary Figure S7).
RQ value of 1 means that E. coli respires aerobically in presence
of the carbohydrate substrates, producing equal molar quantities
of carbon dioxide as the molar amount of oxygen consumed.
Induction was performed for 10 or 21 h and at the end of the
cultivation biomass concentrations of a maximum of 56.5 g L−1
CDW were achieved (Figure 4). Samples were obtained during
the bioreactor cultivation at different time points, for preRumA
Frontiers in Microbiology | www.frontiersin.org 6 September 2019 | Volume 10 | Article 2133
fmicb-10-02133 September 12, 2019 Time: 16:21 # 7
Ongey et al. Bioprocess Development for RumA Production in E. coli
FIGURE 2 | Screening cultivation-relevant parameters of Escherichia coli W3110 pLEOgrA∗M1. (A) Growth (OD600) of cultures in the first row of the 24-microwell
plates induced with 20 µM IPTG. (B) Dissolved oxygen concentration (DO) of cultures before and after boosting/inductions. (C) pH of cultures before and after
boosting/induction. Time intervals from 0 to 14 h represent the culture in a shake flask. The curves for the DO and pH after induction are average values measured
from all wells in each column of the 24 microwell plate. The plotted raw data is shown in Supplementary Figure S9.
analyses starting from 2 h before induction right up to 20 h after
induction. His6-RumM and His6-GFP-TEV-preRumA were co-
purified using His-tag spin columns. Results from SDS-PAGE
analyses indicated strong expression of both constructs within
5 h after induction (Figure 4A). Product concentrations were
estimated to be> 150 mg L−1 for His6-RumM and> 120 mg L−1
for His6-GFP-TEV-preRumA. The changes in production levels
from 5 h after induction throughout the entire cultivation were
not very significant (Figure 4B).
In vivo Dehydration of preRumA by
RumM
Data describing time-dependent changes in the concentrations of
preRumA, partially modified intermediates thereof and RumA as
the final product would be helpful in deciphering mechanisms of
LanM enzymes and provide molecular details that may further
identify other unknown features that assist in the process.
Although overexpression of both, His6-GFP-TEV-preRumA and
His6-RumM, were already significantly high within 5 h after
induction, it was not possible to determine at this time whether
the formation of the PTMs on preRumA were already achieved.
Prior to the fed-batch bioreactor cultivations, it was assumed
that ample time should be allowed for the PTMs to form, since
other studies suggested that the modifying enzyme may require
longer time to catalyze formation of PTMs (Thibodeaux et al.,
2014; Repka et al., 2017). Taking these into consideration, we
investigated modification of preRumA at different time points
during the fed-batch bioreactor cultivations.
Mass spectrometric analyses of preRumA cleaved from the
chimeric His6-GFP-TEV-preRumA show that the precursor
was fully dehydrated (or tetra-dehydrated) barely 1 h after
IPTG induction, whereas as expected, for the extract obtained
before induction, no peak was detected in the mass spectrum
belonging to either tetra-dehydrated, partially dehydrated
or non-dehydrated preRumA (Figure 5). Triple dehydrated
preRumA [m/z(z=5) = 1,092.92] was evident in all the samples
from 1 h post-induction but the peak strength was very weak
compared to the tetra-dehydrated version [m/z(z=5) = 1,089.72].
Considering the different intermediate products of preRumA,
fluctuations were observed in all samples except for the negative
control sample obtained 2 h before induction (Figure 6A).
For instance, unmodified preRumA was apparent at 1 h post-
induction (Figure 6B) but was almost disappearing at 5 h
(Figure 6C) to accumulate again around 8 h post-induction
(Figure 6D). Furthermore, in Figure 6D (8 h post-induction)
and Figure 6G (17 h post-induction), the signal intensity of
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FIGURE 3 | Expression optimization. The left panel indicates online GFP fluorescence measurements of E. coli W3110 pLEOgrA∗M1 cultivated in 24-microwell
plates. (A–D) Represents rows of the 24-microwell plates while 1–6 represents the columns (see plate layout in Supplementary Figure S2). Each graph/gel
therefore represents a row on the plate and the well numbers are indicated. Glucoamylase concentrations (in U L−1) added to wells 1–6 of each row are indicated in
the graph. IPTG concentrations (µM) are also shown. The right panel shows the SDS-PAGE analyses of corresponding soluble His6-RumM (r1) and soluble
His6-GFP-TEV-preRumA (r2) extracts obtained at the end of the cultivation. See Supplementary Figure S4 for full gel images. Average trendlines and error bars in
the chart show the extend to which the fluorescence signals vary across the different cultures.
undehydrated preRumA is higher than the intensity at 1 h
post-induction. Whereas it is almost undetectable at 11 h
(Figure 6E), 14 h (Figure 6F), and 20 h (Figure 6H) after
induction. The current data also shows that the changes in
unmodified preRumA directly affect the single and double
dehydrated components while the triple dehydrated version
of preRumA remained overwhelmingly present throughout
the cultivation. The fluctuations in the various intermediate
components are expected since the fed-batch cultivation system
may allow the expression of target proteins as the cells continue
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FIGURE 4 | Fed-batch cultivation for RumA production with E. coli W3110 pLEOgrA∗M1. (A) SDS-PAGE showing expression of His6-RumM and
His6-GFP-TEV-preRumA from –2 to 20 h after induction. The amount of BSA (in µg, used as quantitative standard) were loaded is indicated on the gel. Full gel
images are displayed in Supplementary Figure S8. (B) Cell dry weight (CDW, g L−1), OD583-Cedex, expression of His6-RumM (mg L−1) and
His6-GFP-TEV-preRumA (mg L−1), glucose (g L−1) and acetate (g L−1) values are shown. Data points are the mean values obtained from duplicate cultivations and
error bars indicate ± SD. Values after 27 h represent only one cultivation since the second cultivation was stopped 10 h after induction.
to receive more nutrients and grow, thereby providing a constant
substrate pool for RumM.
Lanthionine Formation in preRumA by
RumM in vivo
The dehydratase function of RumM discussed in the previous
section creates active centers for the cyclase domain to perform
its function and since there is no difference in mass between
the dehydrated peptide and the cyclized version, we could not
detect ring formation from the ESI-MS data alone. Therefore,
the precursor ion representing the tetra-dehydrated preRumA
was isolated and channeled to the ion-routing multipole of the
mass spectrometer for tandem MS measurements. The penta-
charged peptide ion [m/z(z=5) = 1,089.72] was fragmented
using high-energy collisional dissociation to generate product
ions having distinctive characteristics. In our previous report,
we have already identified specific product ions that are
produced as a result of the cross-linking in the core peptide
(Ongey et al., 2018).
An internal ion [m/z(z=5) = 1,067.30] is produced as a result
of cleavage of peptide bonds linking both the N- and C-terminal
sides of Ile8 in the core peptide of preRumA. This ion is
characteristic of a cross-linkage between Thr7 and Cys12 (Ring
A). Another important internal ion is produced by cleavage
of peptide bonds linking both the N- and C-terminal sides
of Phe21 [m/z(z=5) = 1,060.51]. This represents Ring B which
is formed via a cyclization reaction between Ser9 and Cys23.
It was shown that Dhb16 is not engaged in any cross-linking
reaction, leaving Dhb22 and Cys24 as the remaining residues
which form Ring C (Dabard et al., 2001; Ongey et al., 2018).
Other product ions shown in the spectra in Figure 7 represent
different fragments resulting from preRumA fragmentation. The
objective was to determine at what time these rings begin to
form. Results show that there was no ring formation within 1 h
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FIGURE 5 | ESI-MS spectra indicating dehydration of preRumA from bioreactor cultivation of recombinant E. coli W3110 pLEOgrA∗M1. (A–H) Represent samples
obtained from –2 (negative control before induction) – 20 h post IPTG induction at an interval of 3–4 h. TEV-digested extracts of His6-GFP-TEV-preRumA were
purified using ZipTips and directly injected into the mass spectrometer. The m/z(z=5) = 1,089.72 peak represents tetra-dehydrated preRumA, while the minor peak
represents the loss of three water molecules from preRumA. Molecular weight of non-dehydrated preRumA is 5,515.60 Da [m/z(z=5) = 1,104.12].
of induction (Figure 7B), i.e., no product ion was identified
representing either Ring A or Ring B. This therefore indicates that
although the tetra-dehydrated preRumA was evidently present at
1 h post-induction, the cyclization reactions took a longer time
to complete since fully functional thioether rings were identified
from 2.5 h post-induction as shown in Figures 7C,D.
DISCUSSION
This study describes a bioprocess strategy to achieve
biotechnological relevant production of lanthipeptides in
high cell density bioreactor cultivations using ruminococcin-A
as an example. The data reported herein were extracted from a
combination of glucose-limited fed-batch cultivation methods,
ESI-MS and tandem ESI-MS. Information derived from the
data may be adapted to improve the biosynthesis pathway.
These techniques can also be employed to quantify in vivo
dehydroamino acids formation and lanthionine modifications
catalyzed by lanthionine-generating enzymes during the
production process in bioreactor cultivations.
The heterologous E. coli strain harboring the RumA
biosynthesis machinery demonstrated stable growth and
production characteristics during the two bioreactor cultivations,
suggesting that the strain could also be processed under large-
scale conditions with limited complications. The concentrations
of His-tag purified His6-GFP-TEV-preRumA and His6-RumM
obtained from the bioreactor cultivations were in the range of
120–200 mg L−1. Considering that preRumA is one sixth of
the size of His6-GFP-TEV-preRumA, it can be estimated that
120 mg L−1 of the chimeric construct would yield > 10 mg L−1
of pure and functionally modified preRumA, which doubles
the amount initially obtained from shake flask cultivation
using complex media (Ongey et al., 2018). Additional studies
to ascertain the influence of oscillating conditions on strain
behavior and product quality during large-scale industrial
bioreactor scenarios may be necessary to further evaluate the
robustness of the strain.
However, the modification machinery of lanthipeptides is
very complex, which hinders the establishment of standard
quantitative approaches that can decipher the kinetic events
of lanthionine synthetases. That is why the lab-scale fed-batch
bioreactor cultivations were further exploited in conjunction
with mass spectrometry to derive some information regarding
the kinetics of preRumA modifications. The potential of mass
spectrometry assays cannot be underestimated since they are
capable of detecting and distinguishing peptide species that are
relevant to determine the type of changes that occur during the
dehydration and cyclization reactions (Thibodeaux et al., 2014).
Tandem MS data shows that fully active preRumA with all the
necessary thioether cross-bridges was apparent around 2.5 h
post-induction. There was no evidence of cyclization at 1 h post-
induction although the tetra-dehydrated preRumA was evidently
present. These results are comparable to the modification rates
obtained from in vitro studies involving class II lanthipeptide
synthetases ProcM and HalM2 (Thibodeaux et al., 2014).
The fact that dehydration and cyclization occur at different
time suggests that the dehydratase and cyclase reactions of
LanM enzymes are independent of each other, corroborating
an earlier report where they showed that the two reactions
are largely independent for ProcM, with the dehydration
reactions preceding cyclization (Mukherjee and Van Der
Donk, 2014). This is in contrast with class I nisin cyclase
which appears to install thioether rings before dehydration is
completed, thereby generating partially dehydrated product due
to inaccessibility of nisin dehydratase to target threonine or
serine residue (Repka et al., 2017). However, this is conceivable
since a single multi-domain enzyme is involved in class II
peptide modifications while class I peptides are modified
by two separate enzymes, one catalyzing dehydration and
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FIGURE 6 | Fluctuations of incomplete preRumA dehydration products. (A–H) Represent samples obtained from –2 (negative control before induction) to 20 h post
IPTG induction at an interval of 3 h. The products are: unmodified preRumA [m/z(z=5) = 1,104.12], single dehydrated [m/z(z=5) = 1,100.52], double dehydrated
[m/z(z=5) = 1,096.92], and triple dehydrated [m/z(z=5) = 1,093.32]. Notice that the m/z value in the spectrum may represent a different isotope of the same product.
the other catalyzing cyclization (Repka et al., 2017). Based
on the growth profile of the strain during the bioreactor
cultivations and observations from SDS-PAGE and tandem
MS data, we concluded that it would be reasonable to
stop the bioreactor cultivation around 10 h post IPTG
induction. That is why the second cultivation was discontinued
at this point, which also happens to be the point where
GFP fluorescence signals also began to decline during the
microscale cultivations.
It may be challenging to provide a simple explanation for
the constant accumulation of triple dehydrated preRumA. Since
dehydration and cyclization reactions cannot be distinguished
in time and space (Lubelski et al., 2009), the current data
does not indicate which of the target threonine or serine
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FIGURE 7 | Tandem MS experiments of tetra-dehydrated preRumA [m/z(z=5) = 1,089.72]. (A) Schematic structure of fully modified preRumA. The processed
ESI-MS2 data displayed in the spectra were obtained at 1 h (B) 2.5 h (C) and 4 h (D) post IPTG induction. Intensive ion series representatives of Ring A and Ring B
are indicated by arrows.
residue in the core peptide of preRumA is unmodified in
the triple-dehydrated version. Furthermore, tandem MS of
the triple dehydrated component could not supply adequate
fragmentation data to determine this because the amount
of the component present in the sample was not enough.
Additionally, there is no general rule regarding the directionality
of catalysis involving lanthionine-generating enzymes because
while some follow an N→C-terminal mode of catalysis
(Lubelski et al., 2009), others prefer the C→N-terminal mode
(Krawczyk et al., 2012). Therefore, it is not enough to
just assume that the extreme C- or N-terminal threonine is
the unmodified residue in this case. A more concentrated
sample may be applied to enhance the signal strength of
the triple-dehydrated component and allow generation of
enough tandem MS data.
Initially, microscale cultivations involving the easy fed-batch
technique that makes use of an enzyme-based automated
glucose-delivery system in a mineral salt-based medium
was applied to produce the peptide in E. coli. Microscale
cultivation is an innovative strategy that facilitates bioprocess
development by reducing experimental costs and allowing
parallel assessment of different process relevant parameters.
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The development and application of the convenient EnBase
technology (Krause et al., 2016) which allows a continuous
controlled delivery of glucose to the culture, revolutionized
this aspect by allowing consistent data extraction for these
parameters that could be directly applied in large-scale
production scenarios. Since class II lanthionine synthetases
utilize cofactors such as Zn2+ and Mg2+ in their catalysis
(Garg et al., 2013; Yang and van der Donk, 2015; Repka et al.,
2017), and the precursor peptide preRumA does not contain
additional building blocks other than the canonical amino
acids, cultivation in this medium was be able to facilitate
formation of the PTMs in the peptide. The process was
established by running parallel 24-microwell plate cultivations
to optimize IPTG induction concentration and to establish
a general overview of the strain behavior under different
scenarios. Data obtained from these experiments were
effortlessly transferred to the lab-scale high cell density
bioreactor cultivation.
The rate of glucose release in the 24-microwell plate
cultivations was controlled by altering the amount of
glucoamylase in the EnPresso medium. Glucoamylase catalyzed
the release of glucose from a soluble complex polysaccharide
component of the medium in a concentration-dependent
manner (Šiurkus et al., 2010; Glazyrina et al., 2012; Krause
et al., 2016). Higher concentrations of the glucoamylase
generated excess glucose in the medium. Report elsewhere
shows that when high concentrations of IPTG is used
to induce a recombinant gene, glucose uptake capacities
of E. coli cells are severely reduced, and their abilities to
respire optimally depreciates, leading to formation and
accumulation of acetate (Neubauer et al., 2003). Acetate
accumulation may explain why the pH of the plate cultures
decreased with increasing concentration of glucoamylase.
Overaccumulation of acetate may become toxic and slow cell
growth, although E. coli may also oxidize the organic acid as
an alternative carbon source (Roe et al., 2002; Neubauer et al.,
2003). Nevertheless, to circumvent eventual acetate toxicity,
feeding rate was controlled in the bioreactor cultivations
by maintaining glucose concentration in the culture broth
below 2 g L−1.
We took notice of the fact that the thickness of bands on
SDS-PAGE representing target proteins extracted from end point
samples obtained during the 24-microwell plate cultivations
did not directly correlate with GFP fluorescence signals. Since
the biosynthesis pathway requires the expression of both the
precursor peptide and the modifying enzyme, we posited
that it would be interesting to quantify product formation
before and after the fluorescence signals began to decline, to
ascertain expression quality. Therefore, samples were collected
at different time points during the bioreactor cultivations and
results from SDS-PAGE showed that IPTG induction of 10 h
is enough to obtain good expression of both modifying enzyme
and the substrate.
One limitation of the current study is that the precursor
substrate is fused to a larger protein (GFP) that may interfere with
the natural dynamics of the catalytic process. However, previous
work indicated that the fusion of GFP to preRumA does not
interfere with the activity of RumM on the precursor peptide. In
fact, His6-RumM was able to interact and form complexes with
the precursor peptide fused to the C-terminus of GFP (Ongey
et al., 2018), indicating that the peptide is highly exposed to
allow such interactions. Nevertheless, an alternative strategy is
to use a different lanthipeptide that reproducibly expresses in
E. coli without the need of fusion partner. Another limitation
was the lack of an adequate method to quench the activity of
RumM from the time the cells were collected throughout the
process of extracting and analyzing preRumA. It is conceivable
that the enzyme may have exhibited some activity during this
time, thereby rendering our report on the modification kinetics
inadequate. However, the fact that fully dehydrated preRumA was
visibly present within 1 h of induction, but no ring was detected
in the same sample may indicate otherwise. It was expected that
if RumM was still actively catalyzing PTM formation during
sample processing and measurements, thioether cross-bridges
would have also been detected in this sample. The data reported
herein qualitatively illustrates that it is possible to apply a
combination of bioreactor fermentation and mass spectrometry
to study in vivo kinetics of lanthipeptide modification, setting
the basis for more rigorous investigation in that direction.
Nevertheless, better approaches are needed to quench possible
side reactions during sample processing to give a clearer view
of the in vivo modification process. Additionally, a system that
allows MS measurements in real time would be more useful
in generating accurate quantitative data. We strongly believe
that data from the optimized in vivo modification experiments
would supply more information to enable the establishment of
improved biotechnological systems to produce lanthipeptides.
CONCLUSION
The data presented herein describes the production process of
modified preRumA, established by applying consistent glucose-
limited fed-batch cultivations from microwell- to bioreactor-
scale. The model example illustrates that it is possible
to produce extensively modified lanthipeptides in E. coli
under standard fed-batch cultivation conditions without the
requirements of additional cultivation media supplements. The
heterologous strain demonstrated robustness judging from the
two cultivations performed, while production yields in the
range of 120–200 mg L−1 and some information about in vivo
lanthionine synthesis by LanM enzymes were obtained. Results
also suggest that in vivo catalysis by lanthionine-generating
enzymes may be faster than what is observed in in vitro
experiments. The dehydratase and cyclase reactions catalyzed
by RumM is independent of each other and depending on the
complexity of the ring architecture in the peptide, cultivation
of heterologous E. coli hosts may be finished already 10 h
after induction.
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